The effect of posterior vitreous detachment on the prognosis of branch retinal vein occlusion

Introduction: To evaluate whether posterior vitreous detachment (PVD) improves treatment outcomes.Methods:The medical records of treatment-naive patients followed up for a minimum of six months due to retinal vein occlusion between January 2007 and January 2016 were reviewed. Patients with initial PVD were excluded. Correlation analysis and binary logistic regression analysis were used to determine the relationship between categorical variables and treatment outcomes. A subgroup analysis (steroids vs anti-VEGFs) was also performed.Results: The study included 95 eyes of 95 patients with macular edema due to retinal vein occlusion. Patients in both groups [central retinal vein occlusion (CRVO) and branch retinal vein occlusion (BRVO)] were similar in terms of demographic data and showed similar improvement during the study. The patients who underwent intravitreal steroid injection (IVD or IVTA) were 12.35 times (95% CI: 4.03-37.85) more likely to develop PVD. The patients in steroid group had a statistically significantly high correlation with visual and anatomic improvements, especially after 5 months of follow-up. The median time of PVD was 5 months (2-11).Conclusion: Commonly used drugs in intravitreal pharmacotherapy induce PVD, which plays an important role for the treatment of underlying macular edema.

Download Full-text

Intravitreal Actilyse® injection to induce posterior vitreous detachment in eyes with recent onset of retinal vein occlusion

Spektrum der Augenheilkunde ◽

10.1007/s00717-017-0351-z ◽

2017 ◽

Vol 32 (1) ◽

pp. 39-45

Author(s):

Thomas Bertelmann ◽

Stefan Strodthoff ◽

Walter Sekundo ◽

Stefan Mennel

Keyword(s):

Retinal Vein Occlusion ◽

Posterior Vitreous Detachment ◽

Recent Onset ◽

Vitreous Detachment ◽

Vein Occlusion

Download Full-text

Modern concept in pathophysiology and therapy of branch retinal vein occlusion

Klinische Monatsblätter für Augenheilkunde ◽

10.1055/s-2005-922204 ◽

2005 ◽

Vol 222 (S 4) ◽

Author(s):

J Rehák

Keyword(s):

Retinal Vein Occlusion ◽

Branch Retinal Vein Occlusion ◽

Modern Concept ◽

Vein Occlusion

Download Full-text

Retinal circulation times in branch retinal vein occlusion

Korean Journal of Ophthalmology ◽

10.3341/kjo.1995.9.2.107 ◽

1995 ◽

Vol 9 (2) ◽

pp. 107 ◽

Cited By ~ 7

Author(s):

Gumin Kang ◽

Jaeheung Lee

Keyword(s):

Retinal Vein Occlusion ◽

Branch Retinal Vein Occlusion ◽

Retinal Circulation ◽

Vein Occlusion

Download Full-text

Retinal Vascular Occlusive Disorders - Risk Factors

International Journal of Innovative Research in Medical Science ◽

10.23958/ijirms/vol03-i02/07 ◽

2018 ◽

Vol 3 (02) ◽

Author(s):

Shivcharan Lal Chandravanshi, Sunil Kumar Shrivastava, Priyanka Agnihotri, Smriti Gupta

Keyword(s):

Risk Factors ◽

Retinal Vein Occlusion ◽

Central Retinal Vein Occlusion ◽

Branch Retinal Vein Occlusion ◽

Retinal Artery Occlusion ◽

Artery Occlusion ◽

Vein Occlusion ◽

Department Of Ophthalmology ◽

Retinal Artery ◽

Central Retinal Vein

Aims and Objective - The aim of the present study is to identify risk factors associated with different retinal vascular occlusive diseases (RVOD), such as central retinal artery occlusion (CRAO), hemi-retinal artery occlusion (HRAO), branch retinal artery occlusion (BRAO), cilioretinal artery occlusion (Cilio-RAO), central retinal vein occlusion (CRVO), branch retinal vein occlusion (BRVO), and hemi-retinal vein occlusion (HRVO). Patients and Method - A cross-sectional study on 114 consecutive subjects, aged 24-96 years who have attended at the outpatient department of ophthalmology at Shyam Shah Medical College, Rewa, MP, were included in the study. The Duration of study was January 2016 to December 2017. Only patients with CRAO, BRAO, HRAO, Cilio-RAO, CRVO, BRVO, and HRVO were included in the study. Other retinal vascular disorders such as diabetic vaso-occlusive disease, anterior and posterior ischemic and non-ischemic neuropathy, hypertensive retinopathy, sickle cell retinopathy, retinal telangiectasia, retinopathy of prematurity, were excluded from study. Results - We have included 114 patients, 64 cases (56.14%) males, 50 (43.85%) females, aged 56+/-8 years (range 24-96 years). Bilateral retinal vascular occlusive disorders were seen in only 4 cases (3.5%). Two patients have bilateral CRVO followed by one case of bilateral BRVO and one case of bilateral CRAO. Out of 114 patients, branch retinal vein occlusion was seen in 62 cases (54.38%), followed by central retinal vein occlusion in 36 cases (31.57%), CRAO in 8 cases (7.01%), and hemi- retinal vein occlusion in 4 cases (3.50%). Hypertension was the most common, (40 cases, 35.08%) risk factor identified for retinal vascular occlusive disorders followed by diabetes 24 cases (21.05%), combined diabetes and hypertension in 22 cases (19.29%), and atherosclerosis in 18 cases (15.78%). Conclusions - Retinal vascular occlusive diseases have systemic as well as ocular risk factors. Understanding of these risk factors is essential for proper treatment of RVOD. Timely identification of risk factors for RVOD may helpful in decreasing ocular and systemic morbidity in these patients.

Download Full-text